{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:01:05Z","timestamp":1793228465311,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005940","name":"Danish Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Cancer Research Fund"},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nilsson Cancer Fund"},{"name":"Kamprad Fund"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.urology.2015.08.018","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T08:22:51Z","timestamp":1442305371000},"page":"1212-1217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations"],"prefix":"10.1016","volume":"86","author":[{"given":"Patrick","family":"Joost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-6986","authenticated-orcid":false,"given":"Christina","family":"Therkildsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7856-0057","authenticated-orcid":false,"given":"Mev","family":"Dominguez-Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mef","family":"Nilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2015.08.018_bib0010","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2009.07.039","article-title":"Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome","volume":"137","author":"Stoffel","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.urology.2015.08.018_bib0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch-repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2015.08.018_bib0020","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2015.08.018_bib0025","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/jnci\/djs351","article-title":"Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome","volume":"104","author":"Win","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2015.08.018_bib0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer","volume":"348","author":"Lynch","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2015.08.018_bib0035","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1200\/JCO.2001.19.20.4074","article-title":"MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families","volume":"19","author":"Vasen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2015.08.018_bib0040","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.juro.2010.12.102","article-title":"Upper urinary tract carcinoma in Lynch syndrome cases","volume":"185","author":"Crockett","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.08.018_bib0045","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.23508","article-title":"The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome","volume":"123","author":"Watson","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2015.08.018_bib0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-5347(01)62926-4","article-title":"Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options","volume":"160","author":"Sijmons","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2015.08.018_bib0055","first-page":"1635","article-title":"The tumor spectrum in HNPCC","volume":"14","author":"Watson","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urology.2015.08.018_bib0060","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/sj.onc.1209229","article-title":"Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract","volume":"25","author":"Mongiat-Artus","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.urology.2015.08.018_bib0065","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.eururo.2008.08.008","article-title":"Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum","volume":"54","author":"Roupret","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2015.08.018_bib0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.eururo.2012.07.047","article-title":"Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer","volume":"63","author":"Skeldon","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2015.08.018_bib0075","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/jmg.2010.076992","article-title":"Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers","volume":"47","author":"van der Post","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.urology.2015.08.018_bib0080","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1136\/jmg.2003.017871","article-title":"Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma","volume":"41","author":"Roupret","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.urology.2015.08.018_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2407-5-23","article-title":"Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma","volume":"5","author":"Ericson","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urology.2015.08.018_bib0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0090-4295(99)00399-4","article-title":"Absence of microsatellite instability in transitional cell carcinoma of the bladder","volume":"55","author":"Bonnal","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urology.2015.08.018_bib0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.eururo.2005.11.024","article-title":"Infrequent microsatellite instability in urothelial cell carcinoma of the bladder in young patients","volume":"49","author":"Mongiat-Artus","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2015.08.018_bib0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1746-1596-9-126","article-title":"Heterogenous mismatch-repair status in colorectal cancer","volume":"9","author":"Joost","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.urology.2015.08.018_bib0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-0004.2008.01125.x","article-title":"Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations","volume":"75","author":"Barrow","year":"2009","journal-title":"Clin Genet"},{"key":"10.1016\/j.urology.2015.08.018_bib0110","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","article-title":"Risks of less common cancers in proven mutation carriers with lynch syndrome","volume":"30","author":"Engel","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2015.08.018_bib0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10689-008-9193-9","article-title":"Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer","volume":"7","author":"Myrhoj","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1016\/j.urology.2015.08.018_bib0120","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/02841861003782017","article-title":"NORDCAN\u2014a Nordic tool for cancer information, planning, quality control and research","volume":"49","author":"Engholm","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.urology.2015.08.018_bib0125","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1053\/j.gastro.2005.09.012","article-title":"Cancer characteristics in Swedish families fulfilling criteria for hereditary nonpolyposis colorectal cancer","volume":"129","author":"Bermejo","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.urology.2015.08.018_bib0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10689-007-9164-6","article-title":"Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC)","volume":"7","author":"Geary","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1016\/j.urology.2015.08.018_bib0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-012-9573-z","article-title":"The spectrum of urological malignancy in Lynch syndrome","volume":"12","author":"Barrow","year":"2013","journal-title":"Fam Cancer"},{"key":"10.1016\/j.urology.2015.08.018_bib0140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts","volume":"62","author":"Vasen","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.urology.2015.08.018_bib0145","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1053\/j.gastro.2014.04.001","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer","volume":"147","author":"Giardiello","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.urology.2015.08.018_bib0150","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1470-2045(09)70041-5","article-title":"Management of extracolonic tumours in patients with Lynch syndrome","volume":"10","author":"Koornstra","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urology.2015.08.018_bib0155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1464-410X.2010.09443.x","article-title":"Towards a rational strategy for the surveillance of patients with Lynch syndrome (hereditary non-polyposis colon cancer) for upper tract transitional cell carcinoma","volume":"106","author":"Acher","year":"2010","journal-title":"BJU Int"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515008249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515008249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T13:14:31Z","timestamp":1620825271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429515008249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0090429515008249"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2015.08.018","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2015.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}